Correction: Combined inhibition of PI3K and Src kinases demonstrates synergistic therapeutic efficacy in clear-cell renal carcinoma
Oncotarget
.
2019 Mar 15;10(22):2236.
doi: 10.18632/oncotarget.26807.
Authors
Roelants Caroline
1
2
,
Giacosa Sofia
1
,
Pillet Catherine
3
,
Bussat Remi
1
,
Champelovier Pierre
4
,
Bastien Olivier
5
,
Guyon Laurent
1
,
Arnoux Valentin
4
,
Cochet Claude
1
,
Filhol Odile
1
Affiliations
1
Université Grenoble-Alpes, Inserm U1036, CEA, BIG-BCI, Grenoble, France.
2
Inovarion, Paris, France.
3
Université Grenoble-Alpes, Inserm U1038, CEA, BIG-BGE, Grenoble, France.
4
Centre Hospitalier Université Grenoble-Alpes, CS 10217, Grenoble, France.
5
Université Grenoble-Alpes, CNRS-CEA-INRA, Laboratoire de Physiologie Cellulaire et Végétale, Grenoble, France.
PMID:
31040915
PMCID:
PMC6481339
DOI:
10.18632/oncotarget.26807
Abstract
[This corrects the article DOI: 10.18632/oncotarget.25700.].
Publication types
Published Erratum